Research Article

Mortality Predictive Value of APACHE II and SOFA Scores in COVID-19 Patients in the Intensive Care Unit

Table 3

Based on organic complications in survive and nonsurvive patients.

VariableSurvived n = 90Nonsurvived n = 114 value

Kidney, n (%)20 (22.2)87 (76.3)≤0.001
 AKI14 (15.6)73 (64)≤0.001
 Uremia20 (22.2)82 (71.9)≤0.001
 Oliguria09 (7.9)NA
 Anuria05 (4.4)NA
 Dialysis1 (5)15 (17.2)0.001
Liver, n (%)26 (28.9)41 (36)0.298
 ↑ Enzyme23 (25.6)25 (21.9)0.619
 Bilirubinemia17 (18.9)28 (24.6)0.396
 Coagulopathy2 (2.2)28 (24.6)≤0.001
Hematologic, n (%)78 (86.7)104 (91.2)0.365
 Thrombocytopenia6 (6.7)24 (21.1)≤0.001
 Leukocytosis36 (40)66 (57.9)0.016
 Lymphopenia69 (76.6)103 (90.4)0.017
 Anemia18 (20)40 (35.1)0.020
Heart, n (%)3 (3.3)70 (61.4)≤0.001
 ↓ EF ≤40%3 (3.3)4 (3.5)0.629
 Vasopressor1 (1.1)70 (61.4)≤0.001
 Inotrope1 (1.1)13 (11.4)0.001
Neurologic, n (%)2 (2.2)15 (13.2)0.005
 Loss of consciousness010 (8.8)NA
 Seizure00NA
 Lethargy02 (1.8)NA
 Delirium2 (2.2)5 (4.9)0.468
 Paresthesia/plegia01 (0.9)NA
GI, n (%)8 (44.4)3 (50)0.063
 Bleeding4 (22.2)1 (16.6)0.172
 Diarrhea4 (22.2)2 (33.3)0.409
 Melena2 (11.1)0NA
Respiratory, n (%)2 (66.6)23 (45.1)≤0.001
 Hemoptysis06 (11.7)NA
 Pneumothorax010 (19.6)NA
 Emphysema05 (9.8)NA
 Effusion1 (33.4)7 (13.7)0.080

AKI: acute kidney injury, EF: ejection fraction, GI: gastrointestinal, and NA: not applicable.